Related Experiment Videos
[Primitive neuroectodermal tumors: difficult tumors versus modern oncology]
V Martínez Ibáñez1, P Abad, N Torán
1Departamento de Cirugía Pediátrica, Hospital Materno-Infantil Vall d'Hebron.
Summary
Primitive peripheral neuroectodermal tumours (PNET) are aggressive thoracic masses in children. Early diagnosis and multimodal treatment are crucial for improving outcomes in these rare, often misdiagnosed, embryonal tumours.
Area of Science:
- Pediatric Oncology
- Thoracic Surgery
- Diagnostic Imaging
Background:
- Primitive peripheral neuroectodermal tumours (PNET) are rare, aggressive small round cell neoplasms.
- PNETs share cellular origins with other high-grade pediatric malignancies like Ewing's sarcoma and neuroblastoma.
- Historically, PNETs have been described in the thoracic-pulmonary region, as first noted by Askin in 1979.
Observation:
- A study observed 5 pediatric PNET cases among 26 thoracic neuroblastomas and 11 mediastinal-thoracic sarcomas.
- Patients presented with thoracic masses infiltrating local structures or as paravertebral intrathoracic masses.
- Diagnosis involved a combination of imaging (X-ray, CT, bone scintigraphy) and histopathological methods (immunocytochemistry, cytology).
Findings:
- One of the five pediatric PNET patients died due to bone marrow infiltration.
- The remaining patients achieved disease-free status, though one relapsed after chemotherapy and required surgical intervention.
- Aggressive local treatment combined with stage IV SIOP chemotherapy for rhabdomyosarcoma was employed.
Implications:
- PNETs exhibit characteristics typical of challenging pediatric cancers, often leading to misdiagnosis.
- Advanced diagnostic techniques like immunohistochemistry, cytogenetics, and molecular genetics are vital for accurate PNET differentiation.
- Improved diagnostic accuracy is essential for tailoring optimal treatment strategies and enhancing the prognosis of these aggressive embryonal tumours.